Tehran University of Medical Sciences
home | Farsi
Print

Shahin Akhondzadeh

Contact Information
Tel: +98-21-55412222
Fax: +98-21-55419113
Address: Roozbeh Psychiatric Hospital, South Kargar Street, Tehean 13337, Iran
Academic Rank
Professor
School
Medicine
Psychiatric
Hospital
Roozbeh
Roozbeh Hospital
Research Center
Psychiatry and Psychology Research Center
About
CV last edited on: 2014/01/12

1.

Fellowship


unit 29 (epilepsy research), INSERM, PARIS, FRANCE, 1999
2.

Ph.D


Division of Neuroscience and Biomedical Systems, IBLS, Faculty of Medicine, Glasgow University, Glasgow, UK, 1993-1995
Thesis Title:Thesis: Studies of Adenosine and GABAA Receptors in Hippocampal Slices
3.

Pharm D


Doctor of Pharmacy , Tehran University of Medical Sciences,, 1985-1991
Thesis Title:The Interaction of GABA and Dopamine on Stereotype Behavior
1.

English


Speaking: Good, Reading: Good, Writing: Good
1.

Avisina Award (Tehran University of Medical Sciences) for Highly Cited Paper, Tehran, Iran (2005).


2.

Avisina Award (Tehran University of Medical Sciences) for publications in international journals, Tehran, Iran (2002).


3.

RAZI Award (national) for the best researcher in clinical sciences, Tehran, Iran (2000)


4.

To obtain Ph.D. degree in neuroscience with first class just in two years in Glasgow University.


5.

Fellow of British Pharmacological Society (FBPharmacolS) (clinical section)


Scientific Position

1.

Assistant Professor


Neurosciences. Brain Research Institute. Niigata University. Niigata, Japan, 1996-1997
2.

Associate Editor


Archive of Iranian Medicine (in English), Tehran, Iran, since2004

English

1.

Gender Differences and Schizophrenia: Evidence for Estrogen Hypothesis (in Persian)


Publisher: Tehran University of Medical Sciences Press, 2005, Original
2.

Principal of Research and Scientific Writing in Medical Sciences


Publisher: Salemi Press, 2003, Original
3.

Encyclopedia of Iranian Medicinal Plants (in Persian)


Publisher: Arjomand Press, 2000, Tehran, Iran, Original
4.

Low-Cost Approaches to Promote Physical and Mental Health: Theory Research and Practice. Edited by Luciano L’Abate. Chapter 6: Herbal Medicine in the treatment of psychiatric and neurological Disorders


Springer 2007, New York, USA, Original

Papers

Farsi

1.

Low-Cost Approaches to Promote Physical and Mental Health: Theory Research and Practice. Edited by Luciano L’Abate. Chapter 6


Authors: Shahin Akhondzadeh
Herbal Medicine in the treatment of psychiatric and neurological Disorders., Year. Springer 2007,
3.

Cyproheptadine in the treatment of autistic disorder: a double-blind and placebo controlled trial. Journal of Clinical Pharmacy and Therapeutics


Authors: AKHONDZADEH S., ERFANI S., MOHAMMADI MR., TEHRANI-DOOST M., AMINI H.
Vol.29, Year. 2004, Page:145-150,
4.

Principal of Research and Scientific Writing in Medical Sciences (in Persian).


Authors: Shahin Akhondzadeh
Salemi Press, Year. 2003,
5.

Encyclopedia of Iranian Medicinal Plants (in Persian)


Authors: Shahin Akhondzadeh
Arjomand Press, Year. 2000,

English

1.

Correlation of adenosinergic activity with superior efficacy of clozapine for treatment of chronic schizophrenia: a double blind randomised trial.


Authors: Ghaleiha A , Honarbakhsh N , Boroumand MA , Jafarinia M , Tabrizi M , Rezaei F , Raznahan M , Akhondzadeh S , Copyright (c) 2011 John Wiley & Sons, Ltd.
Human psychopharmacology , No. 1099-1077 (Electronic) , Year. 20110518 ,
2.

Acetyl-L-carnitine as an adjunctive therapy in the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a placebo-controlled trial.


Authors: Abbasi SH , Heidari S , Mohammadi MR , Tabrizi M , Ghaleiha A , Akhondzadeh S ,
Child psychiatry and human development , No. 1573-3327 (Electronic) , Year. 20110502 ,
3.

Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression.


Authors: Abolfazli R , Hosseini M , Ghanizadeh A , Ghaleiha A , Tabrizi M , Raznahan M , Golalizadeh M , Akhondzadeh S , (c) 2011 Wiley-Liss, Inc.
Depression and anxiety, No. 1520-6394 (Electronic), Year. 20110401,
4.

Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania.


Authors: Amrollahi Z , Rezaei F , Salehi B , Modabbernia AH , Maroufi A , Esfandiari GR , Naderi M , Ghebleh F , Ahmadi-Abhari SA , Sadeghi M , Tabrizi M , Akhondzadeh S , Copyright (c) 2010 Elsevier B.V. All rights reserved.
Journal of affective disorders , No. 1573-2517 (Electronic) , Year. 20110214 ,
5.

Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.


Authors: Zarinara AR , Mohammadi MR , Hazrati N , Tabrizi M , Rezazadeh SA , Rezaie F , Akhondzadeh S , Copyright (c) 2010 John Wiley & Sons, Ltd.
Human psychopharmacology , No. 1099-1077 (Electronic) , Year. 20110211 ,
6.

Amantadine versus methylphenidate in children and adolescents with attention deficit/hyperactivity disorder: a randomized, double-blind trial.


Authors: Mohammadi MR , Kazemi MR , Zia E , Rezazadeh SA , Tabrizi M , Akhondzadeh S , Copyright (c) 2010 John Wiley & Sons, Ltd.
Human psychopharmacology , No. 1099-1077 (Electronic) , Year. 20110211 ,
7.

Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial.


Authors: Akhondzadeh S , Ghayyoumi R , Rezaei F , Salehi B , Modabbernia AH , Maroufi A , Esfandiari GR , Naderi M , Ghebleh F , Tabrizi M , Rezazadeh SA ,
Psychopharmacology , No. 1432-2072 (Electronic) , Year. 20110204 ,
8.

Pharmacotherapy of schizophrenia: ploypharmacy approaches.


Authors: Rahiminejad F , Akhondzadeh S ,
Acta medica Iranica , No. 1735-9694 (Electronic) , Year. 20110131 ,
9.

Health-related quality of life of Iranian children with attention deficit/hyperactivity disorder.


Authors: Jafari P , Ghanizadeh A , Akhondzadeh S , Mohammadi MR ,
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation , No. 1573-2649 (Electronic) , Year. 20110120 ,
10.

Knowledge, attitude, and practice of Iranian adolescent girls towards 3-4-methylenedioxymethamphetamine.


Authors: Rahnavard Z , Eybpoosh S , Akhondzadeh S ,
Saudi medical journal , No. 0379-5284 (Print) , Year. 20110107 ,
12.

Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder.


Authors: Rezaei V , Mohammadi MR , Ghanizadeh A , Sahraian A , Tabrizi M , Rezazadeh SA , Akhondzadeh S , Copyright (c) 2010 Elsevier Inc. All rights reserved.
Progress in neuro-psychopharmacology & biological psychiatry , No. 1878-4216 (Electronic) , Year. 20100913 ,
13.

Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial.


Authors: Akhondzadeh S , Sabet MS , Harirchian MH , Togha M , Cheraghmakani H , Razeghi S , Hejazi SSh , Yousefi MH , Alimardani R , Jamshidi A , Zare F , Moradi A , Copyright (c) 2010 The Authors. JCPT (c) 2010 Blackwell Publishing Ltd.
Journal of clinical pharmacy and therapeutics , No. 1365-2710 (Electronic) , Year. 20100913 ,
14.

The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: a double-blind randomized placebo-controlled trial.


Authors: Abbasi SH , Behpournia H , Ghoreshi A , Salehi B , Raznahan M , Rezazadeh SA , Rezaei F , Akhondzadeh S , 2009 Elsevier B.V. All rights reserved.
Schizophrenia research , No. 1573-2509 (Electronic) , Year. 20100203 ,
15.

Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism.


Authors: Akhondzadeh S , Fallah J , Mohammadi MR , Imani R , Mohammadi M , Salehi B , Ghanizadeh A , Raznahan M , Mohebbi-Rasa S , Rezazadeh SA , Forghani S , Copyright 2009 Elsevier Inc. All rights reserved.
Progress in neuro-psychopharmacology & biological psychiatry , No. 1878-4216 (Electronic) , Year. 20100201 ,
16.

Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial.


Authors: Salehi B , Imani R , Mohammadi MR , Fallah J , Mohammadi M , Ghanizadeh A , Tasviechi AA , Vossoughi A , Rezazadeh SA , Akhondzadeh S , Copyright 2009 Elsevier Inc. All rights reserved.
Progress in neuro-psychopharmacology & biological psychiatry , No. 1878-4216 (Electronic) , Year. 20100201 ,
17.

double-blind, randomized, and placebo-controlled trial of buspirone added to risperidone in patients with chronic schizophrenia.


Authors: Ghaleiha A, Noorbala AA, Farnaghi F, Hajiazim M, Akhondzadeh S.
J Clin Psychopharmacol, Vol.30, Year. 2010, Page:678-82,
18.

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial.


Authors: Akhondzadeh S , Jafari S , Raisi F , Nasehi AA , Ghoreishi A , Salehi B , Mohebbi-Rasa S , Raznahan M , Kamalipour A ,
Depression and anxiety , No. 1520-6394 (Electronic) , Year. 20090707 ,
19.

Major depressive disorder in children and adolescents after renal transplantation.


Authors: Ghanizadeh A , Mansoori Y , Ashkani H , Fallahzadeh MH , Derakhshan A , Shokrpour N , Akhondzadeh S ,
Transplantation proceedings , No. 1873-2623 (Electronic) , Year. 20090623 ,
20.

Comparing the effects of high-dose vitamin E with those of placebo on insulin resistance in patients with schizophrenia treated with olanzapine.


Authors: Salmasi FB , Jazayeri M , Ghaeli P , Hashemian F , Akhondzadeh S , Raisi F , Hosseini SH , Setareh MJ , Khavidaki SD ,
Journal of clinical psychopharmacology , No. 1533-712X (Electronic) , Year. 20090610 ,
21.

Added ondansetron for stable schizophrenia: a double blind, placebo controlled trial.


Authors: Akhondzadeh S , Mohammadi N , Noroozian M , Karamghadiri N , Ghoreishi A , Jamshidi AH , Forghani S ,
Schizophrenia research , No. 0920-9964 (Print) , Year. 20090123 ,
22.

A placebo controlled trial of propentofylline added to risperidone in chronic schizophrenia


[link]
Authors: Akhondzadeh S, Salimi S
British Journal of Clinical Pharmacology, Vol.68, Year. 2009, Page:303-304,
23.

). Effect of ritanserin on negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial


[link]
Authors: Akhondzadeh S, Malek-Hosseini, M
British Journal of Clinical Pharmacology , Vol.68, Year. 2009, Page:304,
24.

Attention deficit hyperactivity disorder in


Authors: Ghanizadeh A, Akhondzadeh S
J Am Acad Psychiatry Law , Vol.37, Year. 2009, Page:278,
25.

The Meeting of Psychiatry and Humanities: An Overview


Authors: AKHONDZADEH S, ABBASI SH.
Vol.2, No.5, Year. 2009,
26.

Herbal medicine and women's mental health


Authors: KASHANI L, AKHONDZADEH S
Journal of Medicinal Plants, Vol.8, Year. 2009, Page:1-6,
27.

Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.


Authors: Akhondzadeh S , Malek-Hosseini M , Ghoreishi A , Raznahan M , Rezazadeh SA ,
Progress in neuro-psychopharmacology & biological psychiatry , No. 0278-5846 (Print) , Year. 20081128 ,
28.

A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia.


Authors: Salimi S , Fotouhi A , Ghoreishi A , Derakhshan MK , Khodaie-Ardakani MR , Mohammadi MR , Noorbala AA , Ahmadi-Abhari SA , Hajiazim M , Abbasi SH , Akhondzadeh S ,
Progress in neuro-psychopharmacology & biological psychiatry , No. 0278-5846 (Print) , Year. 20080305 ,
29.

Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.


Authors: Amiri A , Noorbala AA , Nejatisafa AA , Ghoreishi A , Derakhshan MK , Khodaie-Ardakani MR , Hajiazim M , Raznahan M , Akhondzadeh S , (c) 2007 John Wiley & Sons, Ltd.
Human psychopharmacology , No. 1099-1077 (Electronic) , Year. 20080225 ,
30.

A placebo controlled trial of the selegiline added to risperidone in chronic schizophrenia.


[link]
Authors: Akhondzadeh Sm Amiri A, Kashani L
British Journal of Clinical Pharmacology , Vol.65, Year. 2008, Page:981-981 ,
31.

Herbal medicines in the treatment of depression and anxiety


[link]
Authors: Kamalipour, M., Akhondzadeh, S.H., Rezazadeh, Sh
Journal of Medicinal Plants , Vol.7, Year. 2008, Page: 1-7,
32.

Cardiovascular Effects of Allium Sativum (Garlic): An Evidence-Based Review


Authors: BATHAEI FS, AKHONDZADEH S
Journal of Tehran University Heart Center , Vol.3, Year. 2008, Page: 5-10,
33.

Crocus sativus L. (saffron) in the treatment of premenstrual syndromes: A double-blind


Authors: Agha-Hosseini M, Kashani L, Aleyaseen A, Ghoreshi A, cH. Rahmanpour H. Zarinara AR, Akhondzadeh S
randomized and placebo controlled trial British Journal of Gynecology (BJOG), Vol.115, Year. 2008, Page:515-519,
34.

A double-blind


Authors: AKHONDZADEH S, TAJDAR H, MOHAMMADI MR, MOHAMADDI M
Year. 2008,
35.

Allopurinol as adjunctive therapy in intractable epilepsy: a double-blind and placebo-controlled trial.


Authors: Togha M , Akhondzadeh S , Motamedi M , Ahmadi B , Razeghi S ,
Archives of medical research , No. 0188-4409 (Print) , Year. 20070312 ,
36.

Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial.


Authors: Akhondzadeh S , Tabatabaee M , Amini H , Ahmadi Abhari SA , Abbasi SH , Behnam B ,
Schizophrenia research , No. 0920-9964 (Print) , Year. 20070205 ,
37.

Piracetam added to risperidone in patients with autistic disorder: a double-blind placebo controlled trial.


Authors: Akhondzadeh S, Tagdar H, Mohammadi MR
British Journal of Clinical Pharmacology, Vol.63, Year. 2007, Page:777-777,
38.

A clinical trial of adjunctive celecoxib treatment in patients with chronic schizophrenia: a double-blind and placebo controlled trial.


Authors: Akhondzadeh S, Tabatabaee M, Amini H, Ahmadi-Abhari S A
British Journal of Clinical Pharmacology , Vol.63, Year. 2007, Page:: 774-774,
39.

Autism spectrum disorders: etiology and pharmacotherapy


Authors: MOHAMMADI MR, AKHONDZADEH S.
Current Drug Therapy , Vol.2, Year. 2007, Page:97-103,
40.

Attention-deficit/hyperactivity disorder: etiology and pharmacotherapy.


Authors: MOHAMMADI MR, AKHONDZADEH S
Expert Review in Neuroterapeutics , Vol.7, Year. 2007, Page:195-201,
41.

Cardiovascular Effects of Antidepressants and Mood Stabilizers


Authors: MALEKI J. AKHONDZADEH S
The Journal of Tehran University Heart Center , Vol.2, Year. 2007, Page:133-136,
42.

Combination of citalopram and nortriptyline in the treatment of severe major depression: a double-blind and placebo- controlled trial


Authors: Raisi F., Habibi N., Nasehi AA., Akhondzadeh S
Therapy, Vol.4, Year. 2007, Page:187-192,
43.

Attention-deficit/hyperactivity disorder: etiology and pharmacotherapy.


Authors: Noorbala AA , Akhondzadeh S ,
Archives of Iranian medicine , No. 1029-2977 (Print) , Year. 20061025 ,
44.

Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial.


Authors: Akhondzadeh S , Milajerdi MR , Amini H , Tehrani-Doost M ,
Bipolar disorders , No. 1398-5647 (Print) , Year. 20061017 ,
45.

Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia.


Authors: Akhondzadeh S , Rezaei F , Larijani B , Nejatisafa AA , Kashani L , Abbasi SH ,
Schizophrenia research , No. 0920-9964 (Print) , Year. 20060522 ,
46.

Herbal medicine in the treatment of Alzheimer's disease.


Authors: Akhondzadeh S , Abbasi SH ,
American journal of Alzheimer's disease and other dementias , No. 1533-3175 (Print) , Year. 20060425 ,
47.

Is there a relationship between estrogen serum concentration and symptom severity throughout the menstrual cycle of patients with schizophrenia?


Authors: Akhondzadeh S, MOKHEBERI K, KASHANI L
British Journal of Clinical Pharmacology , Vol.61, Year. 2006, Page:619-619,
48.

Antipsychotic Drugs and Sudden Death


Authors: ABBASI SH, AFKHAM K, AKHONDZADEH S
The Journal of Tehran University Heart Center , Vol.1, Year. 2006, Page:5-11,
49.

Pharmacotherapy of schizophrenia: The past, present and future


Authors: AKHONDZADEH S
Current Drug Therapy, Vol.1, Year. 2006, Page:1-7,
50.

Topiramate prevents ecstasy consumption: a case report.


Authors: Akhondzadeh S , Hampa AD ,
Fundamental & clinical pharmacology , No. 0767-3981 (Print) , Year. 20050922 ,
51.

Artificial neural networks in prediction of bone density among post-menopausal women.


Authors: Sadatsafavi M , Moayyeri A , Soltani A , Larijani B , Nouraie M , Akhondzadeh S ,
Journal of endocrinological investigation , No. 0391-4097 (Print) , Year. 20050803 ,
52.

The 5-HT hypothesis of schizophrenia.


Authors: Akhondzadeh S ,
IDrugs : the investigational drugs journal , No. 1369-7056 (Print) , Year. 20050718 ,
53.

Schizophrenia: etiology and pharmacotherapy.


Authors: Mohammadi MR , Akhondzadeh S ,
IDrugs : the investigational drugs journal , No. 1369-7056 (Print) , Year. 20050615 ,
54.

Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial.


Authors: Akhondzadeh S , Tahmacebi-Pour N , Noorbala AA , Amini H , Fallah-Pour H , Jamshidi AH , Khani M , Copyright 2005 John Wiley & Sons, Ltd.
Phytotherapy research : PTR , No. 0951-418X (Print) , Year. 20050502 ,
55.

Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial.


Authors: Amini H , Aghayan S , Jalili SA , Akhondzadeh S , Yahyazadeh O , Pakravan-Nejad M ,
Journal of clinical pharmacy and therapeutics , No. 0269-4727 (Print) , Year. 20050406 ,
56.

Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial.


Authors: Noorbala AA , Akhondzadeh S , Tahmacebi-Pour N , Jamshidi AH ,
Journal of ethnopharmacology , No. 0378-8741 (Print) , Year. 20050214 ,
57.

Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.


Authors: Akhondzadeh S , Safarcherati A , Amini H ,
Progress in neuro-psychopharmacology & biological psychiatry , No. 0278-5846 (Print) , Year. 20050207 ,
58.

Is there an improvement in psychotic symptoms and cognition impairments with the addition of lamotrigine to risperidone in chronic schizophrenia?


Authors: Akhondzadeh S, Makkinejad K, Alem, ZM, MOINOLGHORBAEI M.
Proceeding of British Pharmacological Society., Year. 2005,
59.

Passiflora incarnata in the treatment of attention deficit hyperactivity disorder in children and adolescents: A double blind and randomized trial.


Authors: Akhondzadeh S, Mohammadi Mr, Momeni F, MOSHAVER A..
Proceeding of British Pharmacological Society, Year. 2005,
60.

A double-blind, randomized, placebo-controlled study of allopurinol as adjunctive treatment for acute mania in hospitalized bipolar patients


Authors: AKHONDZADEH S, MILAJERDI MR, AMINI H, MOINOLGHORBAEI M
British Journal of Clinical Pharmacolog, Vol.59, Year. 2005, Page:634-634,
61.

Comparison of specifications, short-term outcome and prognosis of acute myocardial infarction in opium dependent patients and non-dependents


Authors: Davoodi G., Sadeghian S., Akhondzadeh S., Darvish S., Alidoosti M. and Amirzadegan A.
German Journal of Psychiatry , Vol.8, Year. 2005, Page:33-37,
62.

Psyllium decreased serum glucose and glycosylated hemoglobin significantly in diabetic outpatients


[link]
Authors: Ziai SA, Larijani B, Akhoondzadeh S, Fakhrzadeh H, Dastpak A, Bandarian F, Rezai A, Badi HN, Emami T
Ethnopharmacology, Vol.102, Year. 2005, Page:7-202,
63.

Allopurinol as adjunctive treatment for acute mania in hospitalized bipolar patients.


Authors: AKHONDZADEH S, RAFIEE-MILAJERDI M, AMINI H, BATHAI FS. and KAMALIPOUR A.
Therapy 2, Vol.2, Year. 2005, Page:739-744,
64.

Crocus sativus L. in the treatment of mild to moderate depression: A double-blind, randomized and placebo controlled trial. Phytotherapy Research


Authors: AKHONDZADEH S, TAMACEBI-POUR N, NOORBALA AA, AMINI H, FALLAH POUR H, JAMSHIDI AH, KHANI M.
Vol.19, Year. 2005, Page:25-29,
65.

Frequency of myasthenic crisis in relation to thymectomy in generalized myasthenia gravis: a 17-year experience.


Authors: Soleimani A , Moayyeri A , Akhondzadeh S , Sadatsafavi M , Tavakoli Shalmani H , Soltanzadeh A ,
BMC neurology , No. 1471-2377 (Electronic) , Year. 20040927 ,
66.

Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816].


Authors: Akhondzadeh S , Fallah-Pour H , Afkham K , Jamshidi AH , Khalighi-Cigaroudi F ,
BMC complementary and alternative medicine , No. 1472-6882 (Electronic) , Year. 20040920 ,
67.

Prevalence of obsessive-compulsive disorder in Iran.


Authors: Mohammadi MR , Ghanizadeh A , Rahgozar M , Noorbala AA , Davidian H , Afzali HM , Naghavi HR , Yazdi SA , Saberi SM , Mesgarpour B , Akhondzadeh S , Alaghebandrad J , Tehranidoost M ,
BMC psychiatry , No. 1471-244X (Electronic) , Year. 20040511 ,
68.

Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371].


Authors: Akhondzadeh S , Mohammadi MR , Khademi M ,
BMC psychiatry , No. 1471-244X (Electronic) , Year. 20040430 ,
69.

Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial.


Authors: Mohammadi MR , Kashani L , Akhondzadeh S , Izadian ES , Ohadinia S ,
Journal of clinical pharmacy and therapeutics , No. 0269-4727 (Print) , Year. 20040407 ,
70.

Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.


Authors: Akhondzadeh S , Erfani S , Mohammadi MR , Tehrani-Doost M , Amini H , Gudarzi SS , Yasamy MT ,
Journal of clinical pharmacy and therapeutics , No. 0269-4727 (Print) , Year. 20040407 ,
71.

Effects of a fixed dose of Melissa officinalis extract in Alzheimer’s disease: a randomized, placebo controlled trial.


Authors: Noroozian M, Akhondzadeh S, Mohammadi MR., Ohadinia S
International Psychogeriaterics, Vol.15, No.216, Year. 2004,
72.

Ritanserin as an adjunct to lithium and haloperidol for the treatment of patients with acute mania: A double blind and placebo controlled trial


Authors: AKONDZADEH S., MOHAMMADI MR., MAHAJERI H., AMINI H., KASHANI L
British Journal of Clinical Pharmacology, Vol.57, No.670, Year. 2004,
73.

Association between depression and diabetes


Authors: LARIJANI B, KHORAM SHAHI BAYAT M, KHALILI GORGANI M, BANDARIAN F, AKHONDZADEH S, SAJADI SA.
German Journal of Psychiatry , Vol.7, Year. 2004, Page:62-65,
74.

Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trial.


Authors: Akhondzadeh S , Mohajari H , Reza Mohammadi M , Amini H ,
BMC psychiatry , No. 1471-244X (Electronic) , Year. 20031029 ,
75.

Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial.


Authors: Akhondzadeh S , Tavakolian R , Davari-Ashtiani R , Arabgol F , Amini H ,
Progress in neuro-psychopharmacology & biological psychiatry , No. 0278-5846 (Print) , Year. 20030818 ,
76.

Hydroxyzine may be safe and effective in generalised anxiety disorder.


Authors: Akhondzadeh S ,
Evidence-based mental health , No. 1362-0347 (Print) , Year. 20030801 ,
77.

Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial.


Authors: Akhondzadeh S , Noroozian M , Mohammadi M , Ohadinia S , Jamshidi AH , Khani M ,
Journal of neurology, neurosurgery, and psychiatry , No. 0022-3050 (Print) , Year. 20030617 ,
78.

Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial.


Authors: Akhondzadeh S , Noroozian M , Mohammadi M , Ohadinia S , Jamshidi AH , Khani M ,
Journal of clinical pharmacy and therapeutics , No. 0269-4727 (Print) , Year. 20030227 ,
79.

Comparison of Lavandula angustifolia Mill. tincture and imipramine in the treatment of mild to moderate depression: a double-blind, randomized trial.


Authors: Akhondzadeh S , Kashani L , Fotouhi A , Jarvandi S , Mobaseri M , Moin M , Khani M , Jamshidi AH , Baghalian K , Taghizadeh M ,
Progress in neuro-psychopharmacology & biological psychiatry , No. 0278-5846 (Print) , Year. 20030128 ,
80.

Salvia officinalis extract in the treatment of mild to moderate Alzheimer’s disease: a double blind and placebo-controlled trial.


Authors: Akhondzadeh S., Noroozian M. & Mohammadi MR
Proceeding of the British Pharmacological Society at http://www.pa2online/Vol1Issue2abst022.htm, Vol.1, No.2, Year. 2003,
81.

Comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression: A double blind and randomized tria


Authors: Proceeding of the British Pharmacological Society at http://www.pa2online/Vol1Issue2abst021.html
Proceeding of the British Pharmacological Society at http://www.pa2online/Vol1Issue2abst023.html, Vol.1, No.2, Year. 2003,
82.

A clinical trial of adjunctive estrogen treatment in women with chronic schizophrenia: a double blind and placebo controlled study.


Authors: Akhondzadeh S., Nejatisafa AA. & Amini H.
Proceeding of the British Pharmacological Society at http://www.pa2online/Vol1Issue2abst021.html, Vol.1, No.2, Year. 2003,
83.

Effects of a fixed dose of Melissa officinalis extract in Alzheimer’s disease: a randomized, placebo controlled trial


Authors: Akhondzadeh S., Noroozian M., Mohammadi MR., Ohadinia S. & Moin M
British Journal of Clinical Pharmacology, Vol.55, Year. 2003, Page:443-445,
84.

Double blind comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression


Authors: Akhondzadeh S., Faraji H., Sadeghi M., Afkham K., Fakhrzadeh H. Kamalipour A.
Journal of Clinical Pharmacy and Therapeutics, Vol.28, Year. 2003, Page:379-384,
85.

Adjunctive estrogen treatment in women with chronic schizophrenia: a double blind, randomized and placebo controlled trial


Authors: AKHONDZADEH S., NEJATISAFA AK., AMINI H., LARIJANI B., KASHANI L., RAISI F. and KAMALIPOUR A.
Progress in Neuropsychopharmacology and Biological Psychiatry, Year. 2003, Page:1007-1012,
86.

Diazoxide in the treatment of schizophrenia: a novel application of potassium channel openers in the CNS disorders


Authors: AKHONDZADEH S., MOJTAHEDZADEH V. and MIRSEPASSI G.R.
Br. J. Clin. Pharmacology, Vol.54, Year. 2002, Page:40P,
87.

Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind randomized and controlled trial


Authors: AKHONDZADEH S., TAVAKOLIAN R., DAVARI-ASHTIANI R. and AMINI-NOOSHABADI H.
Br. J. Clin. Pharmacology, Vol.54, Year. 2002, Page:39P,
88.

Alzheimer’s disease: Pathophysiology and pharmacotherapy.


Authors: AKHONDZADEH S. & Noroozian M
IDRUGS, Vol.5, Year. 2002, Page:1062-1069,
90.

Diazoxide in the treatment of schizophrenia: a novel application of potassium channel openers in the CNS disorders


Authors: AKHONDZADEH S., MOJTAHEDZADEH V. MIRSEPASSI G.R. and KAMILIPOUR A
J. Clinical Pharmacy and Therapeutics, Vol.27, Year. 2002, Page:453-459,
91.

Cyproheptadine in the treatment of autism


Authors: GUDARZI S., YASAMYM. and AKHONDZADEH S
Eur. Psychiatry, Vol.17, Year. 2002, Page: 230-231,
92.

Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam.


Authors: Akhondzadeh S , Naghavi HR , Vazirian M , Shayeganpour A , Rashidi H , Khani M ,
Journal of clinical pharmacy and therapeutics , No. 0269-4727 (Print) , Year. 20011026 ,
93.

Passionflower in the treatment of opiates withdrawal: a double-blind randomized controlled trial.


Authors: Akhondzadeh S , Kashani L , Mobaseri M , Hosseini SH , Nikzad S , Khani M ,
Journal of clinical pharmacy and therapeutics , No. 0269-4727 (Print) , Year. 20011026 ,
94.

Baclofen versus clonidine in the treatment of opiates withdrawal, side-effects aspect: a double-blind randomized controlled trial.


Authors: Ahmadi-Abhari SA , Akhondzadeh S , Assadi SM , Shabestari OL , Farzanehgan ZM , Kamlipour A ,
Journal of clinical pharmacy and therapeutics , No. 0269-4727 (Print) , Year. 20010405 ,
95.

Double-blind randomized controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawal.


Authors: Akhondzadeh S , Ahmadi-Abhari SA , Assadi SM , Shabestari OL , Kashani AR , Farzanehgan ZM ,
Journal of clinical pharmacy and therapeutics , No. 0269-4727 (Print) , Year. 20010104 ,
96.

Dipyridamole in the treatment of schizophrenia: adenosine-dopamine receptor interactions.


Authors: Akhondzadeh S , Shasavand E , Jamilian H , Shabestari O , Kamalipour A ,
Journal of clinical pharmacy and therapeutics , No. 0269-4727 (Print) , Year. 20000714 ,
97.

Is it time to have another look at lithium maintenance therapy in bipolar disorder?


Authors: Akhondzadeh S , Emamian ES , Ahmadi-Abhari A , Shabestari O , Dadgarnejad M ,
Progress in neuro-psychopharmacology & biological psychiatry , No. 0278-5846 (Print) , Year. 20000203 ,
98.

Piracetam in the treatment of schizophrenia: implications for the glutamate hypothesis of schizophrenia.


Authors: Noorbala AA , Akhondzadeh S , Davari-Ashtiani R , Amini-Nooshabadi H ,
Journal of clinical pharmacy and therapeutics , No. 0269-4727 (Print) , Year. 20000106 ,
99.

Double-blind randomized controlled trial of baclofen in the treatment of opiates withdrawal


Authors: AKHONDZADEH S., AHMADI-ABHARI S.A., ASSADI S.M., SHABESTARI O.L, KASHANI A.R. and FARZANEHGAN, Z.M
Journal of Clinical Pharmacy and Therapeutics, Vol.25, Year. 2000, Page:347-353,
100.

Potentiation of Muscimol-induced long-term depression by benzodiazepines but not zolpidem


Authors: AKHONDZADEH S. KHASHANI L. and MOBASERI M
Br. J. Pharmacology, Vol.135, Year. 2000,
101.

Piracetam in the treatment of schizophrenia: a double-blind, placebo-controlled study


Authors: AKHONDZADEH S., NOORBALA, A.A., DAVARI-ASHTIANI, R., AMINI-NOOSHABADI, H. & SHABESTARI, O.L
Br. J. Clin. Pharmacol, Vol.49, No.507, Year. 2000,
102.

Cyproheptadine in the treatment of chronic schizophrenia: implications for the 5-HT hypothesis of schizophrenia.


Authors: AKHONDZADEH S., MOHAMMADI, M.R., DAVARI-ASHTIANI, R., AMINI-NOOSHABADI, H. & FARZANEHGAN, Z.M
Br. J. Clin. Pharmacol, Vol.49, No.491, Year. 2000,
103.

Potentiation of muscimol-induced long-term depression by diazepam and chlordiazepoxide.


Authors: AKHONDZADEH, S., SHABESTARI, O.L. & FARZANEHGAN, Z.M.
Br. J. Pharmacol, Vol.129, No.163, Year. 2000,
104.

Prevention of muscimol-induced long-term depression by brain-derived neurotrophic factor.


Authors: Akhondzadeh S , Stone T ,
Progress in neuro-psychopharmacology & biological psychiatry , No. 0278-5846 (Print) , Year. 19991221 ,
105.

Hippocampal synaptic plasticity and cognition.


Authors: Akhondzadeh S ,
Journal of clinical pharmacy and therapeutics , No. 0269-4727 (Print) , Year. 19991028 ,
106.

Cyproheptadine in treatment of chronic schizophrenia: a double-blind, placebo-controlled study.


Authors: Akhondzadeh S , Mohammadi MR , Amini-Nooshabadi H , Davari-Ashtiani R ,
Journal of clinical pharmacy and therapeutics , No. 0269-4727 (Print) , Year. 19990624 ,
107.

Potentiation of muscimol-induced long-term depression by benzodiazepines and prevention or reversal by pregnenolone sulfate.


Authors: Akhondzadeh S , Stone TW ,
Pharmacological research : the official journal of the Italian Pharmacological Society , No. 1043-6618 (Print) , Year. 19990429 ,
108.

Combination of clomipramine and nortriptyline in the treatment of obsessive-compulsive disorder: a double-blind, placebo-controlled trial.


Authors: Noorbala AA , Hosseini SH , Mohammadi MR , Akhondzadeh S ,
Journal of clinical pharmacy and therapeutics , No. 0269-4727 (Print) , Year. 19981230 ,
109.

Maintenance of muscimol-induced long-term depression by neurosteroids.


Authors: Akhondzadeh S , Stone TW ,
Progress in neuro-psychopharmacology & biological psychiatry , No. 0278-5846 (Print) , Year. 19970411 ,
110.

Muscimol-induced long-term depression in the hippocampus: lack of dependence on extracellular calcium.


Authors: Akhondzadeh S , Stone TW ,
Neuroscience , No. 0306-4522 (Print) , Year. 19970313 ,
111.

Glutamate-independent long term depression in rat hippocampus by activation GABAA receptors.


Authors: Akhondzadeh S , Stone TW ,
Life sciences , No. 0024-3205 (Print) , Year. 19960618 ,
112.

Induction of a novel form of hippocampal long-term depression by muscimol: involvement of GABAA but not glutamate receptors.


Authors: Akhondzadeh S , Stone TW ,
British journal of pharmacology , No. 0007-1188 (Print) , Year. 19951127 ,
113.

Potentiation by neurosteroids of muscimol/adenosine interactions in rat hippocampus.


Authors: Akhondzadeh S , Stone TW ,
Brain research , No. 0006-8993 (Print) , Year. 19951114 ,
114.

Interaction between adenosine and GABAA receptors on hippocampal neurones.


Authors: Akhondzadeh S , Stone TW ,
Brain research , No. 0006-8993 (Print) , Year. 19950425 ,
115.

) Neurosteroids potentiate GABA and adenosine inhibition of hippocampal evoked potentials


Authors: AKHONDZADEH, S. & STONE, T.W
Br. J. Pharmacol, Vol.114, Year. 1995, Page:293P,
116.

neurosteroids enhance muscimol and adenosine potentiation in the presence of barium


Authors: AKHONDZADEH, S. & STONE, T.W
Br. J. Pharmacol, Vol.114, Year. 1995, Page: 292P,
117.

Suppression by DIDS of an interaction between adenosine and muscimol in the hippocampus


Authors: AKHONDZADEH, S. & STONE, T.W
Br. J. Pharmacol, Vol.113, Year. 1994, Page:106P,
118.

Enhancement by muscimol of adenosine effects on hippocampal population spikes,


Authors: AKHONDZADEH, S. & STONE, T.W
Br. J. Pharmacol, Vol.112, Year. 1994, Page:612P,
119.

Enhancement by muscimol of adenosine effects on population spikes in the presence of barium


Authors: AKHONDZADEH, S. & STONE, T.W
Canadian J. Physiol. Pharmacol, Vol.72, Year. 1994, Page:503.,
120.

Antidepressant effect of Crocus


Authors: Kamalipour M, Jamshidi AH, Akhondzadeh S

121.

The glutamate hypothesis of schizophrenia


Authors: AKHONDZADEH S
Journal of Clinical Pharmacy and Therapeutics, Vol.23, Page:243-246,
122.


Authors: Zaringhalam, J., Shams, J., Rezazadeh, S., Manaheji, H., Akhondzadeh, S
ASI,
123.

Petal and stigma of Crocus sativus L. in the treatment of depression: A pilot double - blind randomized trial


[link]
Authors: Akhondzadeh Basti, A., Choreishi, S.A., Noorbala, A.A., Akhondzadeh, S.H., Rezazadeh, Sh.
Journal of Medicinal Plants , Vol.7, Page:29-36,
124.

A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone.


Authors: Akhondzadeh S, Geramy M. noorozian M, Ghoreishi A, Karam ghadiri N. ABBASi H, REZAZADEH SA. (2008).
Prog Neuropsychopharmacol Biol Psychiatry , Vol.32, Page:1810-5,
126.

Is there a relationship between estrogen serum level and symptoms severity over the menstrual cycle of schizophrenics


Authors: AKHONDZADEH S, Mokhberi K, AMINI H, Larijani B, Kashani L, Hashemi L, AK Nejatisafa, Shafaei AR.
Therapy , Vol.2, Page:745-751,
127.

Comparison of desmopressin (DDAVP) tablet and intranasal spray in the treatment of central diabetes insipidus.


Authors: Larijani B., Tabatabaei O., Soltani A., Taheri E., Pajouhi M., Bastanhagh MA., Akhondzadeh S., Mahmoodi M., Bandarian F., Mohammadzade N.,
DARU , Vol.13, Page:155-159,

Abstracts and Presentations

English

1.

Salvia officinalis extract in the treatment of mild to moderate Alzheimer’s disease: a double blind and placebo-controlled trial


In VII World Conference on Clinical Pharmacology and Therapeutics IUPHAR- Division of Clinical Pharmacology.
Location: Florence, Italy,
Date: 2000-
Authors: Akhondzadeh S., Noroozian M. & Mohammadi MR. (2003)
Type : خلاصه, شركت كننده ,
2.

Comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression: A double blind and randomiz


In VII World Conference on Clinical Pharmacology and Therapeutics IUPHAR- Division of Clinical Pharmacology
Location: Florence, Italy,,
Date: 2000-
Authors: Akhondzadeh S., Faraji H. & Sadeghi M. (2003)
Type : خلاصه, شركت كننده ,
1.

Referee of International Scientific Journals


Others,

Addiction

Journal of Clinical Pharmacy and Therapeutics

BMC Pharmacology

BMC Alternative and Complementary Medicine

BMC Psychiatry

Journal of Neurology, Neurosurgery and Psychiatry

Journal of Clinical Psychopharmacology

Nutrition

Psychiatric Research

Current Drug Therapy

Expert Review in Neurotherapeutics

Progress in Neuropsychopharmacology and Biological Psychiatry

Behavioral Brain Research

Schizophrenia Research

Schizophrenia Bulletin

Psychopharmacology

Clinical Psychopharmacology

Biological Psychiatry

1.

Computer Knowledge


Microsaft Office

Powerpoint

SPSS

Sigmaplot

Instat

1.

Member of General Council of Glasgow University


Activity Type:Member
2.

Member of Scottish Neuroscience Group


Activity Type:Member
1. My main research interest is:.

 The negative modulators of GABAA receptors in the     treatment of dementia*

The role of GABAA receptors in the synaptic plasticity and cognition

*The Glutamate, 5-HT and adenosine hypotheses of schizophrenia

* Indirect modulators of dopamine receptors

* Pharmacotherapy of schizophrenia

* Pharmacotherapy of addiction 

* Pharmacotherapy of  Bipolar Disorder

* Pharmacotherapy of ADHD

* Pharmacotherapy of Autism

   

 

Top